Millennium Management’s Century Therapeutics IPSC Stock Holding History

Millennium Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Buy	4,667,063 +4,056,676	+665%	+$8.53M	﹤0.01%	2120
2025 Q4	$607K	Sell	610,387 -133,394	-18%	-$81.4K	﹤0.01%	4819
2025 Q3	$370K	Sell	743,781 -68,432	-8%	-$36.9K	﹤0.01%	5243
2025 Q2	$454K	Buy	+812,213	New	+$436K	﹤0.01%	4964
2025 Q1	–	Sell	-1,607,174	Closed	-$1.62M	–	6120
2024 Q4	$1.62M	Buy	1,607,174 +1,466,415	+1,042%	+$2M	﹤0.01%	3799
2024 Q3	$241K	Sell	140,759 -237,874	-63%	-$466K	﹤0.01%	5331
2024 Q2	$966K	Buy	378,633 +21,232	+6%	+$67.1K	﹤0.01%	4133
2024 Q1	$1.49M	Buy	357,401 +218,441	+157%	+$925K	﹤0.01%	3978
2023 Q4	$461K	Buy	+138,960	New	+$253K	﹤0.01%	4690
2023 Q3	–	Sell	-56,009	Closed	-$177K	–	6330
2023 Q2	$177K	Sell	56,009 -19,545	-26%	-$63K	﹤0.01%	5165
2023 Q1	$262K	Sell	75,554 -153,304	-67%	-$673K	﹤0.01%	5002
2022 Q4	$1.17M	Buy	228,858 +161,345	+239%	+$1.52M	﹤0.01%	4005
2022 Q3	$668K	Buy	67,513 +6,946	+11%	+$73.2K	﹤0.01%	4703
2022 Q2	$509K	Buy	+60,567	New	+$594K	﹤0.01%	4937
2021 Q4	–	Sell	-69,024	Closed	-$1.74M	–	7091
2021 Q3	$1.74M	Sell	69,024 -112,140	-62%	-$3.04M	﹤0.01%	4082
2021 Q2	$5.32M	Buy	+181,164	New	+$4.6M	﹤0.01%	2677

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management's IPSC Position: Q1 2026 in Review

Millennium Management increased its Century Therapeutics (IPSC) stake by 665% in Q1 2026, buying an estimated $8.53M and bringing the position to 4,667,063 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

Millennium Management first reported a position in IPSC in Q2 2021 and has held it in 16 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Millennium Management held 4,667,063 shares of Century Therapeutics worth $10.5M as of Q1 2026.
Millennium Management bought 4,056,676 Century Therapeutics shares in Q1 2026, an estimated $8.53M.
Century Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2120 holding.
Millennium Management first reported a position in Century Therapeutics in Q2 2021 and has held it in 16 quarters since.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.